PMID: 2487608Jan 1, 1989Paper

Second transplants

Clinical Transplants
A Yanagiya, J M Cecka

Abstract

1. One-year graft survival for recipients of second cadaver renal allografts was 66%, 10% below that of first transplant recipients. The poor second graft survival rates have not improved since the introduction of cyclosporine A in 1984. 2. The major difference between first and second transplants was a higher rate of immunological failures in the first 3 months. Whether or not the second transplant functioned on the first day was a good indication of the outcome. 3. The degree of HLA mismatching in the first transplant affected second graft survival. When there were no HLA-B,DR mismatches in the first transplant, 1-year second graft survival was 72% compared to 66% when there were mismatches. 4. HLA-A,B,DR matching in the second transplant also improved second graft survival from 65% for completely mismatched grafts to 78% when there were no antigens mismatched. 5. The duration of the first transplant was an important consideration in second graft survival. When the first transplant had functioned for more than 1 year, second graft survival was 74%. When the first graft had been lost within 3 months, second graft survival was less than 60%. 6. Early second graft function in patients whose first transplant had functioned more t...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Transplants
D K Imagawa, J M Cecka
Clinical Transplants
M Hirata, P I Terasaki
Clinical Transplants
Y C Zhou, J M Cecka
© 2022 Meta ULC. All rights reserved